Early cyclosporine blood levels impact the incidence of acute rejection and overall mortality in the first year after heart transplantation.
Gómez-Sánchez
M A
MA
Heart Failure and Transplantation Program, Hospital 12 de Octubre, Madrid, Spain.
Delgado
J F
JF
Escribano
P
P
Santos
M
M
Sotelo
T
T
Gil
R
R
Hernández-Afonso
J
J
Ortuño
B
B
Romero
F
F
Sáenz de la Calzada
C
C
Rodriguez
J E
JE
Rufilanchas
J J
JJ
D016572:Cyclosporine / Q000097:blood* / Q000627:therapeutic use; D016903:Drug Monitoring; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology* / Q000517:prevention & control; D016027:Heart Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D006439:Hemodynamics; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood* / Q000627:therapeutic use; D015994:Incidence; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000627:therapeutic use; D011184:Postoperative Period; D012189:Retrospective Studies; D015996:Survival Rate; D013997:Time Factors
D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine; D008775:Methylprednisolone